What Is Weight Redistribution and Why Does It Happen?

Weight redistribution is the shift of body fat from one storage site to another, often without a major change in total body weight. Your scale might read the same number for years while fat quietly migrates from your hips and thighs toward your midsection, or from just beneath the skin to deeper deposits around your organs. This process is driven by hormones, aging, genetics, sleep, stress, and sometimes medications or disease. Understanding why fat moves matters more than most people realize, because where fat sits in your body can be more consequential for your health than how much of it you carry.

Not All Fat Is the Same

The body stores fat in distinct compartments, and these compartments behave very differently. Subcutaneous fat, the layer you can pinch between your fingers, sits just under the skin and is especially concentrated in the thighs, hips, and buttocks. Visceral fat, by contrast, is packed deep inside the abdomen around your liver, intestines, and other organs. A third type infiltrates the muscles themselves.

These depots are not just different addresses for the same substance. Visceral fat cells are more metabolically active, release fatty acids more readily, and respond more strongly to stress hormones than subcutaneous fat cells do. Subcutaneous fat, on the other hand, is better at absorbing circulating fats and triglycerides from your bloodstream, acting more like a stable storage unit.¹ When the body redistributes fat from subcutaneous depots to visceral ones, it is effectively moving energy reserves from a relatively benign compartment to one that actively disrupts metabolism.

How Hormones Drive Fat Around the Body

Hormones are the primary remote control for where your body decides to park fat. Two hormonal systems matter most: sex hormones and cortisol.

Estrogen is the clearest example. Before menopause, estrogen actively directs fat toward the hips, thighs, and buttocks and away from the abdomen. When estrogen levels drop during the menopausal transition, that protective pattern reverses. Fat migrates from peripheral subcutaneous depots, especially the gluteofemoral region, toward central visceral stores. Skeletal muscle also suffers, because muscle tissue contains estrogen receptors that help with fiber repair and maintenance. Without adequate estrogen, muscle breaks down more easily, and the combination of visceral fat gain with muscle loss creates what researchers call sarcopenic obesity.²

Cortisol, the body’s primary stress hormone, pushes fat in a similar direction. When cortisol is chronically elevated, whether from psychological stress, medical conditions, or medication, fat preferentially expands in the central and visceral compartments while peripheral subcutaneous depots can actually shrink.³ Research has shown that people who carry more abdominal fat secrete significantly more cortisol during stressful situations, suggesting a feedback loop: stress promotes belly fat, and belly fat may amplify the stress response.⁴

What Happens as You Age

Even without dramatic hormonal shifts like menopause, aging itself reshuffles body composition. The pattern is remarkably consistent across populations: muscle mass declines, visceral fat increases, and fat infiltrates muscle tissue. This is not just cosmetic. Fat that accumulates within and between muscle cells causes direct damage, disrupting the cellular machinery that burns fatty acids and producing reactive molecules that trigger inflammation.⁵

The process feeds on itself. As fat infiltrates muscle, the muscle becomes less effective at burning fuel and more resistant to insulin. Insulin resistance, in turn, promotes further fat storage in exactly the wrong places. Inflammatory signals from fatty muscle leak into the bloodstream and disturb adipose tissue elsewhere, creating a cycle of local fat buildup, inflammation, and metabolic dysfunction that spreads system-wide.⁵ Observational studies consistently show that this combination of muscle loss and ectopic fat accumulation explains a large share of the metabolic deterioration seen in older adults, independent of other risk factors.⁶

Genetics and Why Fat Distribution Differs Between the Sexes

If you have ever noticed that men and women tend to store fat in strikingly different places, genetics is a major reason why. Large genome-wide studies have identified dozens of genetic regions that influence where the body deposits fat, and many of these show pronounced sex differences. A major meta-analysis identified 13 genetic loci associated with waist-to-hip ratio, and seven of those had a much stronger effect in women than in men.⁷ These genetic influences operate independently of overall body fat, meaning two people can carry the same total amount of fat but distribute it very differently based on their genetic background.

Further analysis has revealed that in women, the tissues most strongly enriched for fat-distribution genes are those derived from mesenchymal progenitor cells, including adipose tissue and musculoskeletal tissue, along with tissues involved in female reproduction. This suggests that the characteristically female pattern of storing fat in the legs and trunk is driven largely by gonadal hormones acting on these specific cell lineages.⁸ In practical terms, your genes set the baseline map for fat distribution, and hormones adjust that map throughout life.

When Disease or Medication Moves Fat

Some of the most dramatic examples of weight redistribution come from medical conditions and pharmaceutical side effects. Cushing’s syndrome, caused by prolonged exposure to excess cortisol, produces a textbook pattern: fat accumulates in the face (causing a “moon face” appearance), behind the neck (a “buffalo hump”), and in the abdomen, while the limbs can become thin from simultaneous muscle wasting.³

Lipodystrophy, a group of conditions in which the body loses fat from some areas and sometimes gains it in others, can closely mimic Cushing’s syndrome. A multicenter study found that patients with partial lipodystrophy frequently displayed features like facial fullness, facial plethora, and a dorsocervical fat pad that looked very similar to Cushing’s. The conditions diverged mainly in that Cushing’s patients showed more proximal muscle wasting and osteoporosis.⁹ Distinguishing between the two can be genuinely difficult for clinicians, which matters because the treatments are completely different.

Certain diabetes medications also cause deliberate fat redistribution. Thiazolidinediones, a class of insulin-sensitizing drugs, shift fat away from visceral stores and into subcutaneous tissue. While this increases total body fat and raises weight, the shift away from visceral fat improves insulin sensitivity, which is considered a favorable metabolic trade-off.¹⁰ GLP-1 receptor agonists, the drug class that includes semaglutide and liraglutide, work differently: a meta-analysis found that they reduce both visceral and subcutaneous fat compared to controls.¹¹

Why Sleep and Stress Reshape Your Fat Stores

Sleep deprivation is an underappreciated driver of visceral fat gain. A controlled experiment found that restricting sleep led to increased total abdominal fat, with significant gains in both subcutaneous and visceral abdominal depots, even though total body fat did not change meaningfully compared to the control group. In other words, short sleep did not necessarily make people fatter overall; it rearranged where their fat was stored.¹²

The mechanism appears to involve the suppression of enzymes responsible for breaking down stored triglycerides in visceral fat. When animals are sleep-deprived, the molecular pathway that activates fat breakdown in visceral white adipose tissue becomes less active, causing triglycerides to accumulate there.¹³ Combined with the cortisol-stress connection described earlier, you can see how a modern lifestyle of chronic sleep restriction and chronic stress creates a potent cocktail for visceral fat accumulation, potentially without any change in what the scale says.

Why Visceral Fat Is the Dangerous Kind

The reason researchers and doctors care so much about where fat sits, rather than just how much exists, comes down to the chemical signals that fat tissue produces. Fat is not passive storage; it is an active endocrine organ that secretes molecules called adipokines into the bloodstream. Visceral fat, in particular, releases a profile of these signals that promotes insulin resistance, inflammation, and changes in blood vessel walls that favor atherosclerosis.¹⁴ Some adipokines, like leptin and adiponectin, are beneficial and improve insulin sensitivity and fat burning. Others, including resistin and plasminogen activator inhibitor-1, have the opposite effect and contribute to glucose intolerance and promote the kind of arterial damage that leads to heart attacks and strokes.

This is why two people can have an identical body mass index and very different metabolic health. Someone whose fat is predominantly subcutaneous may have normal blood sugar, healthy cholesterol, and clean arteries. Someone whose fat has redistributed toward visceral stores could be heading toward type 2 diabetes and cardiovascular disease despite weighing exactly the same. BMI, by itself, cannot distinguish between these two scenarios.

Recovery and Refeeding

Weight redistribution is not always a slow, gradual process. One of the more striking examples occurs during recovery from anorexia nervosa. When patients regain weight, fat does not return to the places it came from. Instead, it initially deposits disproportionately in the visceral and intermuscular compartments. A study found that women who had recently restored their weight had significantly more visceral fat and intermuscular fat than healthy control women of similar weight. Visceral fat averaged about 0.75 kg in the recovering patients versus 0.51 kg in controls, and intermuscular fat averaged 0.46 kg versus 0.29 kg.¹⁵

The reassuring finding is that this abnormal central distribution appears to normalize over time. When patients maintained their restored weight for about a year, the fat distribution pattern came to resemble that of the healthy controls.¹⁵ This matters for people in recovery who feel alarmed by the initial belly-centric weight gain. The body appears to prioritize refilling visceral stores first, perhaps because they are the most metabolically active, and then gradually normalizes distribution if weight is maintained.

Can Exercise Change Where Fat Sits?

If hormones, genetics, and aging all conspire to push fat toward the visceral compartment, the practical question is whether anything pushes it back. Exercise does, but the type matters. Aerobic exercise, things like brisk walking, cycling, or jogging, is consistently more effective at reducing visceral fat than resistance training. A randomized trial comparing the two found that aerobic training led to significant reductions in visceral fat, liver fat, and insulin resistance, while resistance training reduced subcutaneous abdominal fat but did not significantly change visceral stores or liver fat.¹⁶

A meta-analysis confirmed this pattern: aerobic exercise produced a clear reduction in visceral fat compared to inactive controls, while resistance training alone did not reach a significant effect on visceral stores.¹⁷ The same pattern held in a trial specifically studying obese adolescent girls, where aerobic exercise reduced both visceral fat and liver fat while resistance exercise did not.¹⁸ This does not mean resistance training is useless; building muscle has its own metabolic benefits. But if your specific goal is to reverse the visceral fat accumulation that comes with aging, menopause, or chronic stress, cardio appears to be the more direct lever.

One encouraging detail is that the amount of aerobic exercise needed to reduce visceral fat may be less than you would expect. The meta-analysis noted that even amounts below the standard recommendations for weight management were enough to produce beneficial changes in visceral fat stores.¹⁷

How Researchers Actually Measure Fat Distribution

One reason the science on weight redistribution has been slow to reach the public is that measuring it is genuinely hard. You cannot tell from a scale or a tape measure how much of your abdominal fat is visceral versus subcutaneous. Even BMI is useless for this purpose.

The gold standard is MRI, which can precisely distinguish fat compartments. DXA scans, which are more widely available and cheaper, can estimate visceral fat, but they come with real limitations. A comparison study found that DXA overestimates lean mass substantially, especially in the abdominal region. In men, DXA reported about 4.10 kg of android lean mass where MRI measured only 1.74 kg. In women, DXA read 2.92 kg versus MRI’s 1.10 kg.¹⁹ DXA did a reasonable job capturing fat measurements including visceral fat, but the lean mass overestimation means that body composition reports from DXA should be read with some caution.

In athletes specifically, DXA visceral fat estimates correlated well with MRI at lower volumes but diverged at higher volumes. For visceral fat volumes above about 600 cubic centimeters, the correlation between DXA and MRI broke down.²⁰ For most people trying to track whether their fat distribution is shifting in the right direction over time, DXA is probably adequate. But if precise visceral fat measurement is clinically important, MRI remains the better tool.

Environmental Chemicals and Sex-Specific Fat Patterns

An emerging area of research is whether environmental pollutants can influence where fat is stored. Endocrine-disrupting chemicals, substances that mimic or interfere with hormones, are plausible candidates because fat distribution is so hormone-dependent. A study analyzing data from a large national health survey found that exposure to certain flame-retardant and plasticizer metabolites was associated with obesity, but the pattern differed between men and women. In women, specific metabolites were linked to increased subcutaneous fat but not visceral fat. In men, a different metabolite was associated exclusively with elevated visceral fat.²¹

This kind of sex-specific chemical effect echoes the genetic findings described earlier and reinforces the idea that male and female bodies are not just storing different amounts of fat but routing it through meaningfully different biological pathways. If environmental exposures can nudge those pathways, it adds another layer of explanation for why some individuals develop unhealthy fat distribution patterns that lifestyle alone cannot fully account for.

An Evolutionary Angle on Female Fat Storage

Why would the female body go to the trouble of rerouting fat away from the abdomen during reproductive years, only to let it drift back after menopause? One hypothesis proposes a surprisingly mechanical explanation. According to the gestational potential space hypothesis, diverting fat from the visceral compartment to the gluteofemoral region frees up physical space in the abdominal cavity for pregnancy and reduces intra-abdominal pressure during gestation.²² This pattern begins at puberty and reverses at menopause, neatly tracking the window of reproductive capacity. After menopause, when pregnancy is no longer possible, the body reverts to the default primate pattern of visceral storage.

Whether or not this hypothesis proves correct, it highlights something important: the female pattern of fat distribution is not just aesthetically different from the male pattern but appears to be an active, regulated process with biological consequences at every stage. It also helps explain why postmenopausal women experience such a sharp increase in cardiovascular risk. The hormonal shift does not just remove a cosmetic feature; it removes a metabolically protective one.